as 10-30-2025 4:00pm EST
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
| Founded: | N/A | Country: |   United States  | 
| Employees: | N/A | City: | BANNOCKBURN | 
| Market Cap: | 4.4B | IPO Year: | N/A | 
| Target Price: | $35.33 | AVG Volume (30 days): | 1.9M | 
| Analyst Decision: | Buy | Number of Analysts: | 9 | 
| Dividend Yield: |  N/A   | Dividend Payout Frequency: | N/A | 
| EPS: | 1.27 | EPS Growth: | 6.77 | 
| 52 Week Low/High: | $21.39 - $35.53 | Next Earning Date: | 10-30-2025 | 
| Revenue: | $5,530,491,000 | Revenue Growth: | 15.79% | 
| Revenue Growth (this year): | 14.8% | Revenue Growth (next year): | 8.56% | 
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 | 
|---|---|---|---|---|---|---|---|---|---|
| Wright Norman L. | OPCH | Director | Sep 9 '25 | Buy | $29.31 | 3,411 | $99,976.07 | 15,501 | |
| GOLDING DAVID W | OPCH | N/A | Aug 21 '25 | Buy | $27.63 | 1,000 | $27,625.00 | 116,525 | |
| SULLIVAN TIMOTHY P | OPCH | N/A | Aug 21 '25 | Buy | $27.51 | 20,000 | $550,200.00 | 49,229 | |
| KRAEMER HARRY M JANSEN JR | OPCH | N/A | Aug 20 '25 | Buy | $27.15 | 36,000 | $977,277.60 | 375,390 | |
| Pate R Carter | OPCH | N/A | Aug 20 '25 | Buy | $27.19 | 750 | $20,391.45 | 41,910 | 
OPCH Breaking Stock News: Dive into OPCH Ticker-Specific Updates for Smart Investing
Argus Research
10 days ago
Argus Research
11 days ago
 
 StockStory
13 days ago
 
 The Fly
13 days ago
MT Newswires
14 days ago
Argus Research
25 days ago
MT Newswires
a month ago
Argus Research
a month ago
The information presented on this page, "OPCH Option Care Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.